Trial
NCT00262951
Chemoradiation in Locally Advanced Pancreatic Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Pancreatic Cancer
Intervention
recombinant interferon alfa
Why stopped
Closed at a planned interim analysis by meeting a predefined toxicity endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28